Proteor USA, a wholly owned subsidiary of the France-based Proteor Group, has signed a deal with Ottobock to acquire a number of lower limb prosthetics products from Freedom Innovations.

The financial terms of the transaction were not disclosed.

Proteor and Ottobock signed the deal in September and it is expected to close by the end of the year.

According to the agreement, the company will obtain a range of Freedom Innovations’ key offerings, including its Plié3 microprocessor knee, Kinnex and Kinterra ankles, as well as Agilix, Highlander, Dynadapt, Sierra and Pacifica feet products.

The addition of Freedom Innovations’ products is expected to bolster Proteor’s lower limb prosthetics portfolio.

Additionally, the companies will combine their teams in the US and Europe and expand worldwide with the aim of facilitating better outcomes for prosthetists and their patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Proteor COO and Managing Board member Edouard Archambeaud said: “Through the acquisition of a significant portion of Freedom Innovations, Proteor is eager to combine the teams in the US and Europe and expand globally, thereby providing a clear choice to prosthetists and their patients for enhanced outcomes.”

Proteor US states president and CEO Matthew Swiggum added: “We are dedicated to providing inventive, dependable products to the orthotic and prosthetic community that offer increased independence with an outstanding product portfolio. Working with the passionate and skilled team at Freedom Innovations is a pleasure we are all looking forward to.”

The proposed transaction will complement Proteor’s recent acquisition of Ability Dynamics’ RUSH Foot portfolio.

The terms of the transaction are subject to the final approval of the Commissioners of the US Federal Trade Commission (FTC).

It needs to satisfy Ottobock’s obligations under the order from the FTC to divest certain assets from Freedom Innovations.

Once the companies receive approval from the FTC, Proteor USA will integrate a significant number of Freedom Innovations team members in manufacturing, sales, marketing, R&D and clinical from Gunnison, Utah, California, US, and Germany.